Modelling trajectories of parentally reported and physician-confirmed atopic dermatitis in a birth cohort study.
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
accepted:
21
09
2021
pubmed:
27
9
2021
medline:
9
3
2022
entrez:
26
9
2021
Statut:
ppublish
Résumé
In a population-based birth cohort, we aimed to identify longitudinal trajectories of atopic dermatitis (AD) during childhood using data from different sources (validated questionnaires and healthcare records). We investigated the impact of different AD definitions on such trajectories and their relationships with various risk factors. Of the 1184 children born into the study, 1083 had information on current AD for at least three follow-ups from birth to age 11 years and were included in the analysis for parentally reported AD (PRAD). Data were transcribed from healthcare records for 916 of 1184 children for the analysis of doctor-diagnosed AD (DDAD). We also derived a composite definition of AD (CDAD) (at least two of the following: PRAD, DDAD, current use of AD treatment). Using latent class analysis (LCA), we determined longitudinal profiles of AD using the three definitions. Filaggrin (FLG) genotype data were available for 803 white participants. For PRAD, LCA identified four AD classes ('no AD', 'persistent', 'early-onset remitting' and 'late-onset'). For DDAD and CDAD, the optimal number of phenotypes was three ('no AD', 'persistent' and 'early-onset remitting'). Although AD classes at population level appeared similar in different models, a considerable proportion of children (n = 485, 45%) moved between classes. The association with FLG genotype, atopic diseases and early-life risk factors was inconsistent across different definitions, but the association with oral food challenge-confirmed peanut allergy was similar, with a nine- to 11-fold increase among children in the persistent AD class. In a CDAD model, compared with the early-onset remitting class, those with persistent AD were significantly more likely to have (at age 3 years) moderate/severe AD, polysensitization and current wheeze, and were less likely to have been breastfed. Standardized composite definitions of AD may help to define AD cases with more precision and identify more consistent long-term trajectories.
Sections du résumé
BACKGROUND
In a population-based birth cohort, we aimed to identify longitudinal trajectories of atopic dermatitis (AD) during childhood using data from different sources (validated questionnaires and healthcare records). We investigated the impact of different AD definitions on such trajectories and their relationships with various risk factors.
METHODS
Of the 1184 children born into the study, 1083 had information on current AD for at least three follow-ups from birth to age 11 years and were included in the analysis for parentally reported AD (PRAD). Data were transcribed from healthcare records for 916 of 1184 children for the analysis of doctor-diagnosed AD (DDAD). We also derived a composite definition of AD (CDAD) (at least two of the following: PRAD, DDAD, current use of AD treatment). Using latent class analysis (LCA), we determined longitudinal profiles of AD using the three definitions. Filaggrin (FLG) genotype data were available for 803 white participants.
RESULTS
For PRAD, LCA identified four AD classes ('no AD', 'persistent', 'early-onset remitting' and 'late-onset'). For DDAD and CDAD, the optimal number of phenotypes was three ('no AD', 'persistent' and 'early-onset remitting'). Although AD classes at population level appeared similar in different models, a considerable proportion of children (n = 485, 45%) moved between classes. The association with FLG genotype, atopic diseases and early-life risk factors was inconsistent across different definitions, but the association with oral food challenge-confirmed peanut allergy was similar, with a nine- to 11-fold increase among children in the persistent AD class. In a CDAD model, compared with the early-onset remitting class, those with persistent AD were significantly more likely to have (at age 3 years) moderate/severe AD, polysensitization and current wheeze, and were less likely to have been breastfed.
CONCLUSIONS
Standardized composite definitions of AD may help to define AD cases with more precision and identify more consistent long-term trajectories.
Substances chimiques
Intermediate Filament Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
274-284Subventions
Organisme : Medical Research Council
ID : MR/K002449/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S025340/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Références
Wollenberg A, Oranje A, Deleuran M et al. ETFAD/EADV eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol 2016; 30:729-47.
Kim Y, Blomberg M, Rifas-Shiman SL et al. Racial/ethnic differences in incidence and persistence of childhood atopic dermatitis. J Invest Dermatol 2019; 139:827-34.
Leung DYM. Atopic dermatitis: age and race do matter! J Allergy Clin Immunol 2015; 136:1265-7.
Silverberg JI, Vakharia PP, Chopra R et al. Phenotypical differences of childhood- and adult-onset atopic dermatitis. J Allergy Clin Immunol Pract 2018; 6:1306-12.
Irvine AD, Mina-Osorio P. Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide. Br J Dermatol 2019; 181:895-906.
Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483-94.
Abuabara K, Hoffstad O, Troxel AB et al. Patterns and predictors of atopic dermatitis disease control past childhood: an observational cohort study. J Allergy Clin Immunol 2018; 141:778-80.e6.
Abuabara K, Yu AM, Okhovat JP et al. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 2018; 73:696-704.
Bieber T, D’Erme AM, Akdis CA et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol 2017; 139:S58-64.
Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014; 134:769-79.
Nakamura T, Haider S, Custovic A. Understanding the heterogeneity of atopic dermatitis in childhood. Curr Allergy Clin Immunol 2018; 31:124-30.
Belgrave D, Henderson J, Simpson A et al. Disaggregating asthma: big investigation versus big data. J Allergy Clin Immunol 2017; 139:400-7.
Hu C, Duijts L, Erler NS et al. Most associations of early-life environmental exposures and genetic risk factors poorly differentiate between eczema phenotypes: the Generation R Study. Br J Dermatol 2019; 181:1190-7.
Paternoster L, Savenije OEM, Heron J et al. Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts. J Allergy Clin Immunol 2018; 141:964-71.
Roduit C, Frei R, Depner M et al. Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood. JAMA Pediatrics 2017; 109:338-42.
Mulick AR, Mansfield KE, Silverwood RJ et al. Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort. Br J Dermatol 2021; 185:526-36.
Nakamura T, Haider S, Colicino S et al. Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors. Br J Dermatol 2019; 181:1272-9.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.):44-7.
Kantor R, Thyssen JP, Paller AS, Silverberg JI. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of ‘atopic dermatitis’. Allergy 2016; 71:1480-5.
Silverberg JI, Thyssen JP, Paller AS et al. What’s in a name? Atopic dermatitis or atopic eczema, but not eczema alone. Allergy 2017; 72:2026-30.
Dizon MP, Yu AM, Singh RK et al. Systematic review of atopic dermatitis disease definition in studies using routinely collected health data. Br J Dermatol 2018; 178:1280-7.
Simpson EL, Keck LE, Chalmers JR, Williams HC. How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies. J Allergy Clin Immunol 2012; 130:137-44.
Dharma C, Lefebvre DL, Tran MM et al. Patterns of allergic sensitization and atopic dermatitis from 1 to 3 years: effects on allergic diseases. Clin Exp Allergy 2018; 48:48-59.
Hua TC, Hwang CY, Chen YJ et al. The natural course of early-onset atopic dermatitis in Taiwan: a population-based cohort study. Br J Dermatol 2014; 170:130-5.
Stensballe LG, Klanso L, Jensen A et al. The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis. Pediatr Allergy Immunol 2017; 28:535-42.
Abuabara K, Magyari AM, Hoffstad O et al. Development and validation of an algorithm to accurately identify atopic eczema patients in primary care electronic health records from the UK. J Invest Dermatol 2017; 137:1655-62.
Bieber T. How to define atopic dermatitis? Dermatol Clin 2017; 35:275-81.
Custovic A, Simpson BM, Murray CS et al. The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol 2002; 13:32-7.
Simpson A, Tan VYF, Winn J et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 2010; 181:1200-6.
Gore C, Peterson CG, Kissen P et al. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age. J Allergy Clin Immunol 2003; 112:702-8.
Nicolaou N, Poorafshar M, Murray C et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125:191-7.e1-13.
Brough HA, Simpson A, Makinson K et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 2014; 134:867-75.e1.
Semic-Jusufagic A, Belgrave D, Pickles A et al. Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study. Lancet Respir Med 2014; 2:621-30.
Simpson A, Brough HA, Haider S et al. Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence. J Allergy Clin Immunol 2020; 145:993-1001.
Bisgaard H, Simpson A, Palmer CN et al. Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med 2008; 5:e131.
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-6.
Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol 2016; 75:681-7.e11.
Williams HC, Burney PG, Hay RJ et al. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131:383-96.
Williams HC, Burney PG, Pembroke AC, Hay RJ. The UK Working Party’s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131:406-16.
Williams HC, Burney PG, Strachan D, Hay RJ. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994; 131:397-405.
Eller E, Kjaer HF, Host A et al. Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol 2010; 21:307-14.
Perkin M, Strachan DP, Williams HC et al. Natural history of atopic dermatitis and its relationship to serum total immunoglobulin E in a population-based birth cohort study. Pediatr Allergy Immunol 2004; 15:221-9.
Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R. A half of schoolchildren with ‘ISAAC eczema’ are ill with allergic contact dermatitis. J Eur Acad Dermatol Venereol 2011; 25:1104-7.
Eichenfield LF, Tom WL, Chamlin SL et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338-51.
Oksel C, Granell R, Mahmoud O et al. Causes of variability in latent phenotypes of childhood wheeze. J Allergy Clin Immunol 2019; 143:1783-90.e11.
Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014; 69:3-16.
Johansson EK, Bergstrom A, Kull I et al. Prognosis of preschool eczema and factors of importance for remission. Acta Derm Venereol 2018; 98:630-5.
Flohr C, Henderson AJ, Kramer MS et al. Effect of an intervention to promote breastfeeding on asthma, lung function, and atopic eczema at age 16 years: follow-up of the PROBIT randomized trial. JAMA Pediatr 2018; 172:e174064.
Gungor D, Nadaud P, LaPergola CC et al. Infant milk-feeding practices and food allergies, allergic rhinitis, atopic dermatitis, and asthma throughout the life span: a systematic review. Am J Clin Nutr 2019; 109 (Suppl. 7):772S-99S.